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EDITORIAL 
Aquaporins and The Nervous System: from Bench to Bedside 
Water is the single most abundant substance in cells and organisms and is an important molecule involved in several 
biochemical processes present in living cells. In humans 60-70% of body weight is water which equilibrates across the lipid 
bilayer in cell membranes. Forty years ago, a small number of scientists argued that specialized water-selective pores are 
necessary to explain the high water permeability of red blood cells and renal tubules. Therefore, the molecular identification of 
a 28 kDa integral membrane protein in these cells has characterized a new stream of research. Aquaporins (AQPs) are 
membrane proteins that transport water and, in some cases, also small solutes such as glycerol and urea. Each subtype has its 
own cellular distribution and distinct regulatory mechanisms of their expression. Their classical role in facilitating trans-
epithelial fluid transport is well understood, as in the urinary concentrating mechanism and gland fluid secretion, while the 
molecular mechanisms to regulate water permeability in the nervous system are still unclear. Maintenance of the ionic and 
osmotic composition and volume of interstitial, glial and neuronal compartments within the nervous system is essential for 
normal function. Small changes in intracellular or extracellular ion or solute composition can dramatically modify bi-directional 
water pathway between the brain and blood vessels and alter cerebrospinal fluid formation, neural signal transduction and 
information processing. To date, only some AQP isoforms (AQP1, 3, 4, 5, 8, 9) have been reported in the central nervous 
system being identified in choroidal cells (AQP1), astrocytes (AQP1, 3, 4, 5, 8, 9), oligodendrocytes (AQP8), neurons (AQP1, 
5, 8), tanycytes (AQP9) and ependymal cells (AQP1, 4, 9). In contrast to numerous studies of AQP localization and function in 
the central nervous system, little information is available on the expression and function of AQPs in peripheral nervous system. 
This issue includes six review articles in which the authors report and explore the recent findings about the involvement of 
AQPs both in peripheral and central nervous system. 
The paper by B. Buffoli summarizes the data about the structure, regulation and function of AQPs, giving more importance to 
their involvement in the nervous system and underlying the development of new methods for diagnosis and therapy diseases. 
The review of R. Albertini and R. Bianchi is focused on the different isoforms of AQP protein that have been identified in glial 
cells in central and peripheral nervous system and in reactive microglial. The chapter supports the idea that AQPs are involved 
in water homeostasis during different glial cell functions, such as differentiation, metabolism and excitability of neurons. 
F. Bonomini and R. Rezzani emphasize the role of some AQPs present in glial cells in the maintenance or/and in the regulatory 
mechanisms of blood brain barrier. 
On the basis of the role of AQPs in brain edema, a personal account of the role of AQPs is then presented by C. Loreto and E. 
Reggio, who summarized the implication of different isoforms of these proteins in relation with vascular diseases and nervous 
system. 
In the literature, there is a lot of evidence that indicates a correlation between the expression of AQPs and the development of 
neurodegenerative diseases in which preservation of brain homeostasis is at risk. The review of E. Foglio and L.F. Rodella was 
to consider this topic concentrating on some neurodegenerative diseases, such as Neuromyielitis Optica, Alzheimer’s Diseases, 
Parkinson’s Diseases, Amyotrophic lateral sclerosis, Transmissible Spongiform Encephalopathies. 
Recent evidence suggests a novel role of AQPs in pain transmission both in the central and peripheral nervous system. In this 
issue, E. Borsani reports the modulation of AQPs both in inflammatory and neuropathic pain considering different animal 
models and knock-out animals. 
In the future, the numerous ongoing studies will certainly reveal other multifunctional roles of these proteins in humans. These 
roles might be exploited clinically by the development of drugs to alter AQP expression or function that could serve in the 
treatment of different diseases associated to peripheral and central nervous system. 
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